Enlivex Therapeutics (ENLV)

• Market cap: $208M
• 1 day: -5.28%
• 5 days: -21.44%
• 1 month: -9.76%
• 3 months: -17.77%
• 6 months: -14.57%
• Year to date: -29.04%
• 1 year: -24.15%
• 5 years: -91.29%
• 10 years: -99.4%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Employees: 36